Possible involvement of endogenous opioid system located downstream of α7 nicotinic acetylcholine receptor in mice with physical dependence on nicotine

Journal of Pharmacological Sciences

Volumn 124, Issue 1, 2014, Pages 47-53

  Ueno, Keiko ^a   Kiguchi, Norikazu ^a   Kobayashi, Yuka ^a   Saika, Fumihiro ^a   Wakida, Naoki ^a   Yamamoto, Chizuko ^a   Maeda, Takehiko ^b   Ozaki, Masanobu ^b   Kishioka, Shiroh ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Corticosterone; Nicotine; Opioid system; Physical dependence; 7 nicotinic acetylcholine receptor (nAChR)

Indexed keywords

BUNGAROTOXIN RECEPTOR; CORTICOSTERONE; DIHYDRO BETA ERYTHROIDINE; METHYLLYCACONITINE; MORPHINE; NALOXONE; NALTREXONE; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTERONE BLOOD LEVEL; DRUG WITHDRAWAL; MALE; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; TOBACCO DEPENDENCE;

ACONITINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BIOLOGICAL MARKERS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; NALOXONE; NICOTINE; OPIOID PEPTIDES; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 84892773116     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13172FP     Document Type: Article

References (38)

1. Hughes JR, Gust SW, Skoog K, Keenan R.M., Fenwick JW Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry. 1991;48:52-59.
2. Williams JM, Steinberg MB, Steinberg M.L., Gandhi KK, Ulpe R, Foulds J. Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother. 2011;12:1799-1812.
3. Beard E, Michie S, Fidler J., West R. Use of nicotine replacement therapy in situations involving temporary abstinence from smoking: a national survey of English smokers. Addict Behav. 2013;38:1876-1879.
4. Clarke PB, Reuben M. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol. 1996;117:595-606.
5. Pontieri FE, Tanda G, Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 1996;382:255-257.
6. Wilkie GI, Hutson PH, Stephens M.W., Whiting P., Wonnacott S. Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem Soc Trans. 1993;21:429-431.
7. McGehee DS, Heath MJ, Gelber S, Devay P., Role LW Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 1995;269:1692-1696.
8. Yang X, Criswell HE, Breese GR Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J Pharmacol Exp Ther. 1996;276:482-489.
9. Boyadjieva NI, Sarkar DK The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sci. 1997;61: PL59-PL66.
10. Kiguchi N, Maeda T, Tsuruga M., Yamamoto A, Yamamoto C, Ozaki M., et al Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice. Brain Res. 2008;1189:70-77.
11. Isola R, Zhang H, Tejwani G.A., Neff NH, Hadjiconstantinou M. Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum. Psychopharmacology. 2009;201:507-516.
12. Gudehithlu KP, Duchemin AM, Tejwani G.A., Neff NH, Hadjiconstantinou M. Nicotine-induced changes of brain β-endorphin. Neuropeptides. 2012;46:125-131.
13. Vincler M. Neuronal nicotinic receptors as targets for novel analgesics. Expert Opin Investig Drugs. 2005;14:1191-1198.
14. Campbell VC, Taylor RE, Tizabi Y. Antinociceptive effects of alcohol and nicotine: involvement of the opioid system. Brain Res. 2006;1097:71-77.
15. Yamamoto A, Kiguchi N, Kobayashi Y., Maeda T, Ueno K, Yamamoto C., et al Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation. Life Sci. 2011;89:956-961.
16. Mellon RD, Bayer BM The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J Pharmacol Exp Ther. 1999;288:635-462.
17. Armario A. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci. 2010;31:318-325.
18. Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci. 2006;27:482-491.
19. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Léna C, Le Novère N, de Kerchove d'Exaerde A, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398:805-810.
20. Damaj MI, Meyer EM, Martin BR The antinociceptive effects of α7 nicotinic agonists in an acute pain model. Neuropharmacology. 2000;39:2785-2791.
21. Abdin MJ, Morioka N, Morita K., Kitayama T, Kitayama S, Nakashima T., et al Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life Sci. 2006;80:9-16.
22. Berrendero F, Kieffer BL, Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci. 2002;22: 10935-10940.
23. Berrendero F, Mendizábal V, Robledo P., Galeote L, Bilkei-Gorzo A, Zimmer A, et al Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci. 2005;25:1103-1112.
24. Zenkar N, Bernstein DE The estimation of small amounts of corticosterone in rat plasma. J Biol Chem. 1958;231:695-701.
25. Malin DH. Nicotine dependence: studies with a laboratory model. Pharmacol Biochem Behav. 2001;70:551-559.
26. Kishioka S, Nishida S, Fukunaga Y., Yamamoto H. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Jpn J Pharmacol. 1994;66:257-263.
27. Ueno K, Maeda T, Kiguchi N., Kobayashi Y, Ozaki M, Kishioka S. Availability of serum corticosterone level for quantitative evaluation of morphine withdrawal in mice. Drug Discov Ther. 2011;5:71-75.
28. 2-adrenoceptors. J Pharmacol Exp Ther. 2000;293:578-584.
29. Nunez C, Földes A, Laorden M.L., Milanes MV, Kovács KJ. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem. 2007; 101:1060-1071.
30. Martín F., Laorden ML, Milanés MV. Morphine withdrawal regulates phosphorylation of cAMP response element binding protein (CREB) through PKC in the nucleus tractus solitarius-A2 catecholaminergic neurons. J Neurochem. 2009;110:1422-1432.
31. Kishioka S, Kiguchi N, Kobayashi Y., Yamamoto C, Saika F, Wakida N., et al Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice. Neurosci Lett. 2013;552:98-102.
32. Biała G., Budzyńska B, Kruk M. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced anti-nociception in mice. Pharmacol Rep. 2005;57:755-760.
33. Lee MC, Wagner HN Jr, Tanada S, Frost JJ, Bice A.N., Dannals RF Duration of occupancy of opiate receptors by naltrexone. J Nucl Med. 1988;29:1207-1211.
34. Ngai SH, Berkowitz BA, Yang J.C., Hempstead J., Spector S. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology. 1976;44: 398-401.
35. Coe JW, Brooks PR, Vetelino M.G., Wirtz MC, Arnold EP, Huang J, et al Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48:3474-3477.
36. Mihalak KB, Carroll FI, Luetje CW Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Mol Pharmacol. 2006;70:801-805.
37. Grabus SD, Martin BR, Damaj MI Nicotine physical dependence in the mouse: involvement of the α7 nicotinic receptor subtype. Eur J Pharmacol. 2005;515:90-93.
38. Stoker AK, Semenova S, Markou A. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology. 2008;54: 1223-1232.